Medtronic plc
HealthcareNYSE:MDT · New York Stock Exchange
-$0.05 today
Vol 3.43M · Avg 9.86M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$36.4B of revenue converted into $4.8B of net income for the selected period. Gross margin is 64.7% and net margin is 13.2%, showing how much revenue survives after costs and taxes. EPS is $3.73, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $36.4B +8.4% | $33.5B +3.6% | $32.4B +3.6% | $31.2B -1.4% | $31.7B | $1.0B | $809.6M | $921.6M |
| Cost of Revenue | $12.7B +9.4% | $11.6B +3.7% | $11.2B +4.6% | $10.7B +5.7% | $10.1B | $344.8M | $725.6M | $804.0M |
| Gross Profit | $23.6B +7.9% | $21.9B +3.6% | $21.1B +3.1% | $20.5B -4.8% | $21.5B | $10.3B | $8.9B | $7.6B |
| Gross Margin | 65.0% -0.3pp | 65.3% -0.0pp | 65.3% -0.3pp | 65.7% -2.3pp | 68.0% | 45.5% | 9.8% | 28.9% |
| Research & Development | $2.9B +5.2% | $2.7B -0.1% | $2.7B +1.4% | $2.7B -1.8% | $2.7B | $378.4M | $983.2M | $1.3B |
| Selling, General & Admin | $11.8B +8.6% | $10.8B +1.1% | $10.7B +3.1% | $10.4B +1.2% | $10.3B | $1.4B | $620.6M | $923.0M |
| Operating Expenses | $17.2B +7.7% | $15.9B -0.3% | $16.0B +6.5% | $15.0B -4.9% | $15.8B | $3.6B | $5.3B | $7.0B |
| Depreciation & Amortization | $0 -100.0% | $2.9B +8.1% | $2.6B -1.9% | $2.7B -0.4% | $2.7B | $1.2B | $374.2M | $1.2B |
| EBITDA | $6.9B -25.7% | $9.2B +12.4% | $8.2B -5.7% | $8.7B -0.9% | $8.8B | $12.6B | -$15.2B | $6.8B |
| EBITDA Margin | 18.8% -8.6pp | 27.5% +2.1pp | 25.3% -2.5pp | 27.9% +0.2pp | 27.7% | 10.0% | 5.6% | 46.3% |
| Operating Income | $6.5B +8.6% | $6.0B +15.8% | $5.1B -6.2% | $5.5B -4.6% | $5.8B | $10.6B | $12.3B | $14.0B |
| Operating Margin | 17.8% +0.0pp | 17.8% +1.9pp | 15.9% -1.7pp | 17.6% -0.6pp | 18.2% | 18.7% | 16.6% | 24.1% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $1.3B | -$1.5B | -$1.6B |
| Interest Expense | $715.0M -1.9% | $729.0M +1.4% | $719.0M +13.1% | $636.0M +15.0% | $553.0M | $969.2M | $1.1B | $1.0B |
| Other Income / Expenses | -$331.0M -1.2% | -$327.0M -6.5% | -$307.0M -153.7% | -$121.0M +48.5% | -$235.0M | -$1.6B | -$1.5B | $1.4B |
| Income Before Tax | $6.1B +9.0% | $5.6B +16.4% | $4.8B -9.8% | $5.4B -2.8% | $5.5B | -$15.6B | $3.3B | $4.9B |
| Pre-Tax Margin | 16.9% +0.1pp | 16.8% +1.8pp | 14.9% -2.2pp | 17.2% -0.2pp | 17.4% | 13.3% | 20.8% | 18.7% |
| Income Tax Expense | $1.3B +38.8% | $936.0M -17.4% | $1.1B -28.3% | $1.6B +246.5% | $456.0M | $666.8M | $1.3B | -$1.6B |
| Net Income | $4.8B +3.0% | $4.7B +26.8% | $3.7B -2.2% | $3.8B -25.4% | $5.0B | $5.0B | $4.9B | $4.8B |
| Net Margin | 13.2% -0.7pp | 13.9% +2.5pp | 11.4% -0.7pp | 12.0% -3.9pp | 15.9% | 7.4% | 12.4% | 17.5% |
| EPS (Basic) | $4 +3.3% | $4 +31.0% | $3 -2.1% | $3 -24.5% | $4 | $1.2B | $400.8M | $703.2M |
| EPS (Diluted) | $4 +3.3% | $4 +30.8% | $3 -2.1% | $3 -24.4% | $4 | $620.6M | $766.2M | $609.4M |
| Weighted Avg Shares | $1.3B -0.3% | $1.3B -3.2% | $1.3B -0.2% | $1.3B -0.9% | $1.3B | $892.2M | $757.8M | $925.8M |
| Weighted Avg Shares (Diluted) | $1.3B -0.1% | $1.3B -3.0% | $1.3B -0.2% | $1.3B -1.4% | $1.4B | $319.6M | $1.2B | $924.4M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$129.95B
Stryker Corporation
NYSE:SYK
$120.03B
Bristol-Myers Squibb Company
NYSE:BMY
$116.51B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$112.66B
GSK plc
NYSE:GSK
$106.56B
Sanofi
NASDAQ:SNY
$106.46B
McKesson Corporation
NYSE:MCK
$94.83B
HCA Healthcare, Inc.
NYSE:HCA
$85.78B
Boston Scientific Corporation
NYSE:BSX
$69.84B
Edwards Lifesciences Corporation
NYSE:EW
$48.81B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does MDT generate?
Medtronic plc (MDT) reported $36.36B of revenue in fiscal 2026.
Is MDT profitable?
Medtronic plc (MDT) reported $4.80B of net income, with a net margin of 13.2%.
Explore More
Continue the stock analysis
Jump to another research area for this company.